In conjunction with the Infectious Disease Research Institute and Mogam Institute for Biomedical Research, South Korea's GC Pharma formed a new company in Seattle dubbed Curevo to conduct vaccine R&D. Release
A new study from the American Society for Microbiology and Research America found that the U.S. public's confidence in vaccines has slipped from 2008. U.S. News & World Report story
Inovio Pharmaceuticals started a phase 2 study of its cancer vaccine VGX-3100 in patients with HPV-related anal dysplasia. Release
Merck's experimental Ebola vaccine has been deployed against an outbreak in the Democratic Republic of Congo. Reuters story
FluGen kicked off a study testing its universal flu vaccine candidate's ability to protect against a flu strain mismatched by 6 years. Release
In an interim analysis of a phase 2 trial, MimiVax said its SurVaxM provided a significant survival benefit in newly diagnosed glioblastoma patients over historical standard of care. Release